The Makerere University Lung Institute (MLI) cordially invites you to attend the upcoming Day of Lung Science (DOLS) Virtual Session.
Theme: Mucosal Vaccine Development within the context of Controlled Human Infection Models.
Date and Time: Thursday 29th February 2024 at 3:00 PM EAT.
Presenter: Assoc. Prof. Sabiiti Wilber, Co-Principal Investigator AfriCHIM programme, Division of Infection and Global Health, School of Medicine, University of St. Andrews, North Haugh
Moderator: Dr. Winters Muttamba, Research Scientists/Coordinator - Vaccine and Epidemics Research Group, MLI.
Register in advance for this meeting:
https://us02web.zoom.us/meeting/register/tZIqcOiopzwtEtFJqFryT4odS9C_UAciD2cU
Summary:
COVID-19 vaccines cannot prevent infection, though they are thought to prevent severe disease. Failure to prevent infection has made COVID-19 persist in vaccinated individuals, all in the face of low vaccination rates in sub-Saharan Africa. The need for vaccines that can prevent COVID-19 infection cannot be over emphasised. Mucosal vaccines are believed to have the ability to prevent infection and controlled human infection models (CHIMs) when deployed have potential to fast track the development of these vaccines. To this end, the talk will address the immunology of mucosal vaccines and the role of CHIM in the African and global contexts.